title: Glucose metabolism, schizophrenia, and antipsychotic drugs: comments to the paper of Dwyer et al.
authors.affiliation: Department of Physiology, Los Andes University Medical School, Mèrida, Venezuela. baptri@douglas.mcgill.ca
authors.forename: T
authors.initials: T
authors.lastname: Baptista
authors.forename: S
authors.initials: S
authors.lastname: Beaulieu
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007328:Insulin / Q000378:metabolism; D009765:Obesity / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D014150:Antipsychotic Agents; D007328:Insulin; D005947:Glucose